期刊文献+

健康体检人群幽门螺旋杆菌检出结果分析 被引量:9

Analysis on the Detection Results of Helicobacter Pylori in Healthy People
下载PDF
导出
摘要 目的了解康体检人群幽门螺旋杆菌的检出率,分析幽门螺旋杆菌感染的流行病学特征,为预防幽门螺旋杆菌感染及防治提供依据。方法选取于2019年2月至2019年4月在锦州医科大学附属第一医院健康管理中心体检的健康体检者2859例,统计健康体检人群幽门螺旋杆菌的检出率;对不同性别、不同年龄的健康体检人群幽门螺旋杆菌检出率的差异进行统计学分析。结果本次共检出幽门螺旋杆菌阳性958人,检出率为33.51%;不同性别、年龄组间幽门螺旋杆菌检出率差异有统计学意义;男性不同年龄组间幽门螺旋杆菌检出率差异有统计学意义,女性不同年龄组间幽门螺旋杆菌检出率差异无统计学意义。结论健康体检人群幽门螺旋杆菌检出率较高,男性高于女性。应鼓励健康人群进行幽门螺旋杆菌筛查并积极防治。 Objective To be informed of the difference in the detection rate of helicobacter pylori(H.pylori)in those receiving health check-up,and to analyze the epidemiological characteristics of H.pylori infection,so as to provide evidence for the prevention and treatment of HP infection.Methods 2859 health subjects were selected from February to April 2019 in the Health Management Center of The First Affiliated Hospital of Jinzhou Medical University and the detection rate of HP was counted.The detection rate of HP in different genders and ages was statistically analyzed.Results A total of 958 people with positive H.pylori were detected,with the detection rate of 33.51%.There were statistically significant differences in the detection rate of H.pylori between groups with different genders and age.The difference of H.pylori detection rate among males in different age groups was statistically significant,while that of females in different age groups was not statistically significant.Conclusion The detection rate of H.pylori in healthy people is higher in males than that in females.Healthy people should be encouraged to screen for H.pylori and actively prevent and cure HP.
作者 祝春梅 孙萌潞 徐锦江 方建梅 Zhu Chunmei;Sun Menglu;Xu Jinjiang;Fang Jianmei(Health Management Center,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000 China;Jinzhou Medical University,Jinzhou 121000 China)
出处 《锦州医科大学学报》 CAS 2020年第1期39-40,46,共3页 Journal of Jinzhou Medical University
基金 辽宁省经济社会发展研究课题立项,项目编号:2018lslktyb-052
关键词 14C呼气试验 幽门螺旋杆菌 健康体检 14-urea breath test helicobacter pylori(H.pylori) health check-up
  • 相关文献

参考文献4

二级参考文献43

  • 1Jenml A, Bray F, Center M M, et al. Global cancer statistis[J]. CA Cancer J Clin, 2011,61 (2) :69 - 90.
  • 2Malfertheiner P, Megraud F, O' Morain C A, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Con- sensus Report[J]. Gut, 2012,61 (5) :646 -64.
  • 3Li X, Zhang Y, Zhang H, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB4113[J]. MolCancerRes, 2011,9(7):824-33.
  • 4Sablet T, Piazuelo M B, Shaffer C I, et M. Phylogeographic origin of Helicobacterpylori is a determinant of gastric cancer risk [ J ]. Gut, 2011,60(9) :1189 -95.
  • 5Volinia S, Calin G A, Liu C G, et al. A microRNA expression signature of human solid tumors defines cancer targets [J].Proc Natl Acad Sci USA, 2006,103(7) :2257 -61.
  • 6Elyaklm E, Sttbon E, Faermann A, et al. hsa-miR-191 is a can- didate oncogene target for hepatocellular carcinoma therapy [ J ]. Cancer Res, 2010,70 ( 20 ) : 8077 - 87.
  • 7January CT, Warm LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2014, 64(21 ) :el-76. DOI:10. 1016/j. jacc. 2014.03. 022.
  • 8Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/ AHA/SCAI Guideline for Peroutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [ J ]. J Am Coil Cardiol, 2011,58(24) :e44-122. DOI:10.1016/j. jacc.2011.08. 007.
  • 9Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association [ J]. Eur Heart J, 2012, 33 (21) :2719-2747. DOI:10. 1093/eurheartj/ehs253.
  • 10Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open- label, randomised, controlled trial [ J ]. Lancet, 2013, 381 (9872) : 1107-1115. DOI : 10. 1016/S0140-6736 ( 12 ) 62177-1.

共引文献101

同被引文献143

引证文献9

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部